By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Corning today announced an agreement to purchase the majority of Becton Dickinson's Discovery Labware unit for $730 million in cash.

BD's Advanced Bioprocessing platform is not included in the deal, BD said.

The deal, which is expected to be completed later this year, will increase Corning's global market access and enhance its product portfolio in drug discovery tools, bioprocess solutions, and laboratory research instruments, Corning said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.